APCER Life Sciences is a biopharmaceutical company founded in 2007 with the slogan "Together for better health." The company operates from its headquarters in the United Kingdom and specializes in providing comprehensive drug safety/pharmacovigilance, medical information, medical writing, regulatory services, quality assurance, and risk management programs to pharmaceutical and biotech companies globally. With a strong focus on patient safety and risk profile management, APCER Life Sciences leverages its medicinal and scientific expertise to address full pharmacovigilance requirements for markets in North America, the UK, and Europe. The company also offers regulatory submissions across 100+ countries and a consultative approach towards audit/inspection readiness. The company boasts scalability with operations across five global offices, housing more than 750 employees in Princeton, NJ, USA; London, UK; Germany; Wan Chai, Hong Kong; and New Delhi and Ahmedabad, India. APCER's status as the preferred choice for pharma companies seeking pre/post-marketing compliance and reporting solutions reflects its reputation in the industry. Despite the absence of recent investment information, APCER Life Sciences remains a significant player in the biopharma, biotechnology, healthcare, life sciences, medical devices, and pharmaceutical industries.
There is no investment information
No recent news or press coverage available for APCER Life Sciences.